Home Stroke Birthday Blessing for Cheryl – Brain Tumour Society (Singapore) Ltd.

Birthday Blessing for Cheryl – Brain Tumour Society (Singapore) Ltd.

 

BTSS celebrated member Cheryl’s birthday today with the delivery of a cake by longtime volunteer Kim and staff Jackie.  We were warmly greeted by Patricia, Cheryl’s sister, who was thankful for us celebrating Cheryl’s 41st birthday.  Cheryl loves being around people and she also loves We Bare Bears!  The room was cheerfully decorated with We Bare Bears’ balloons, posters and sweet treats.  Though she spoke few words, we could feel that Cheryl getting at ease with us as she allowed Kim to pamper her.

The intention was to bless Cheryl with a simple birthday cake, but I left the hospice all toasty and warm.  The extent that Patricia went to make Cheryl’s birthday all about her favourite character showed the bond between the sisters runs deep and strong.  I am reminded that bliss is always there when you look harder.  Thank you Chery and…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Third COVID-19 Vaccine Earns Emergency Use Authorization Following Favorable Advisory Committee Meeting

The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...

Abiraterone Acetate, Apalutamide Likeliest to Improve Survival for Patients with Castration-Sensitive Prostate Cancer

In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...

Women of Minority Race/Ethnicity, Lower Socioeconomic Status Experience Lower Digital Breast Tomosynthesis Access

A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...

Michael Szarek, PhD, on the Outcomes of a Q-TWiST Analysis From the Phase 3 TIVO-3 Study

An analysis revealed that as a third- or fourth-line treatment for RCC, tivozanib significantly increased Q-TWiST compared with sorafenib, primarily through an increase in...

Recent Comments